Gale Pharma (India) Private Limited

Gale Pharma (India) Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U51909TG2013PTC087583 Incorporated 10 May 2013 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2020
₹27.87 Lakh
▼ 67% YoY
Net loss · FY 2020
₹4.42 Lakh
Net margin -15.9%
EBITDA · FY 2020
-₹4.13 Lakh
EBITDA margin -14.8%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Gale Pharma (India) Private Limited

Data last updated:

Gale Pharma (India) Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 May 2013 and has been in existence for over 13 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2013PTC087583. Its GSTIN is 36AAFCG1778B1ZR (Telangana).

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Chilukuri Murali Krishna (Managing Director) and Tipparam Nageshwari.

Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at H.No. 7 – 39 Bapuji Nagar Nacharam, Hyderabad, Telangana, India – 500076.

As per the financials filed for FY 2020, the company reported a revenue of ₹27.87 Lakh, a decline of 67% compared to the previous year. For the same year it recorded a net loss of ₹4.42 Lakh (net margin -15.9%) and EBITDA of -₹4.13 Lakh (EBITDA margin -14.8%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 2% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51909TG2013PTC087583
Registration Number 087583
Incorporation Date 10 May 2013
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 December 2020
Date of Balance Sheet 31 March 2020
Compliance Status Active Compliant

CIN history

Gale Pharma (India) has one previous CIN (Corporate Identification Number): U51909AP2013PTC087583. The current CIN is U51909TG2013PTC087583, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U51909TG2013PTC087583Current
U51909AP2013PTC087583Previous

Contact details

Gale Pharma (India) Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    H.No. 7 – 39 Bapuji Nagar Nacharam, Hyderabad, Telangana, India – 500076
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Gale Pharma (India) Private Limited, buy the company report.

Comprehensive company report
Gale Pharma (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Gale Pharma (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Gale Pharma (India) Private Limited, buy the company report.

Financials of Gale Pharma (India) Private Limited

FY 2020 filings available

Gale Pharma (India) Private Limited reported revenue of ₹27.87 Lakh (down 67% YoY) for FY 2020.

Revenue · FY 2020
₹27.87 Lakh ▼ 67%
Net loss · FY 2020
₹4.42 Lakh margin -15.9%
EBITDA · FY 2020
-₹4.13 Lakh margin -14.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 67%
3 years · compounded
▼ 19%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▼ 51%
3 years · compounded
▼ 81%
5 years · compounded
▼ 60%

Revenue fell 67% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA fell 51% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profit and Loss Statement
Revenue from Operations₹27.87 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹4.13 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹4.42 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profitability
EBITDA Margin-14.8%
Net Profit Margin-15.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Gale Pharma (India) Private Limited, buy the company report.

Board of directors of Gale Pharma (India) Private Limited

Gale Pharma (India) has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Tipparam NageshwariDirector10 May 201313 Years 5 MonthsCurrent
Praveen Kumar Venkata KottacheruvuDirector26 Jun 201511 Years 4 MonthsCurrent
Chilukuri Murali KrishnaManaging Director18 Feb 201610 Years 8 MonthsCurrent

Auditor

Gale Pharma (India) Private Limited is audited by MULLAPUDI & CO for the financial year 2020.

Auditor firmFinancial yearFirm registration number
MULLAPUDI & COFY 2020006707S

Shareholding

The shareholding of Gale Pharma (India) Private Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2019FY 2018FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Gale Pharma (India) Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Gale Pharma (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Gale Pharma (India) has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAFCG1778B1ZRTelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Gale Pharma (India) Private Limited, buy the company report.

Recent activity

Gale Pharma (India) Private Limited has 8 board changes on record since 2013: 3 appointments and 5 cessations. The latest: Sarang Matsendranath Degloorkar ceased to be Director on 01 Jun 2019.

AGM
Gale Pharma (India) Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records.
Filing
Gale Pharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad.
Ceased
Sarang Matsendranath Degloorkar ceased to be Director.
Ceased
Chilukuri Murali Krishna ceased to be Director.
Ceased
Gowri Sankar Kompalli ceased to be Managing Director.
Appointed
Chilukuri Murali Krishna was appointed as Managing Director.
Appointed
Praveen Kumar Venkata Kottacheruvu was appointed as Director.
Ceased
Santha Bijapuri ceased to be Director.
Ceased
Jayasri Busetty ceased to be Director.
Appointed
Tipparam Nageshwari was appointed as Director.
Incorporation
10 May 2013
Gale Pharma (India) Private Limited was registered on 10 May 2013 with Roc Hyderabad & aged 13 years 5 months as per MCA records.

Frequently asked questions

Gale Pharma (India) is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 May 2013 (13+ years old) and is registered under CIN U51909TG2013PTC087583.

Gale Pharma (India) has 3 current directors:

The latest financial statements of Gale Pharma (India) on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.

The GSTIN of Gale Pharma (India) is 36AAFCG1778B1ZR, registered in Telangana.

The CIN (Corporate Identification Number) of Gale Pharma (India) is U51909TG2013PTC087583. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Gale Pharma (India) was incorporated on 10 May 2013, making it 13+ years old. It is registered with the Registrar of Companies, Hyderabad.

Sarang Matsendranath Degloorkar ceased to be Director on 01 Jun 2019. Chilukuri Murali Krishna ceased to be Director on 22 Feb 2016. Gowri Sankar Kompalli ceased to be Managing Director on 22 Feb 2016. Gale Pharma (India) has 8 board changes on record in total.

The registered office of Gale Pharma (India) is at H.No. 7 – 39 Bapuji Nagar Nacharam, Hyderabad, Telangana, India – 500076.

Gale Pharma (India) operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Gale Pharma (India) is compliant as of 24 July 2026. The company is actively filing with the Registrar of Companies.